Literature DB >> 31577871

Affordability Boards - The States' New Fix for Drug Pricing.

Tara Sklar1, Christopher Robertson1.   

Abstract

Mesh：

Year:  2019        PMID： 31577871     DOI： 10.1056/NEJMp1906010

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  Value and affordability of CAR T-cell therapy in the United States.

Authors:  Salvatore Fiorenza; David S Ritchie; Scott D Ramsey; Cameron J Turtle; Joshua A Roth
Journal:  Bone Marrow Transplant       Date:  2020-05-30       Impact factor: 5.483

2.  Pursuing Value-Based Prices for Drugs: A Comprehensive Comparison of State Prescription Drug-Pricing Boards.

Authors:  Liam Bendicksen; Benjamin N Rome; Jerry Avorn; Aaron S Kesselheim
Journal:  Milbank Q       Date:  2021-08-10       Impact factor: 4.911

3.  Characteristics and Price Increases Among Sole-Source, Off-Patent Drugs in the United States, 2008 to 2018.

Authors:  Jonathan D Alpern; Arman A Shahriar; Min Xi; Sunita Thapa; Amy J Kodet; William M Stauffer; Gabriela Vazquez Benitez; Pamala A Pawloski; Steven P Dehmer
Journal:  JAMA Netw Open       Date:  2020-08-03

4.  Characteristics of State Legislation Addressing Prescription Drug Price Increases in the United States, 2020.

Authors:  Arman A Shahriar; Gabriela Vazquez Benitez; Pamala A Pawloski; Steven P Dehmer; Jonathan D Alpern
Journal:  J Gen Intern Med       Date:  2021-05-28       Impact factor: 6.473
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.